Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HTGM

HTG Molecular Diagnostics (HTGM) Stock Price, News & Analysis

HTG Molecular Diagnostics logo

About HTG Molecular Diagnostics Stock (NASDAQ:HTGM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$5.01
$6.80
52-Week Range
N/A
Volume
773,040 shs
Average Volume
294,806 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HTGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HTGM Stock News Headlines

HTGMQ HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics Inc HTGMQ
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
HTG Molecular Diagnostics Inc (HTGMQ)
See More Headlines

HTGM Stock Analysis - Frequently Asked Questions

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) announced its earnings results on Wednesday, November, 10th. The medical research company reported ($0.60) EPS for the quarter, hitting analysts' consensus estimates of ($0.60). The medical research company had revenue of $2.52 million for the quarter, compared to analysts' expectations of $2.90 million. HTG Molecular Diagnostics had a positive trailing twelve-month return on equity of 45.52% and a negative net margin of 324.25%.

HTG Molecular Diagnostics (HTGM) raised $50 million in an initial public offering (IPO) on Wednesday, May 6th 2015. The company issued 3,600,000 shares at $13.00-$15.00 per share. Leerink Partners served as the underwriter for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HTG Molecular Diagnostics investors own include Sangamo Therapeutics (SGMO), Idera Pharmaceuticals (IDRA), NightHawk Biosciences (NHWK), Abeona Therapeutics (ABEO), Exelixis (EXEL), Bionano Genomics (BNGO) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
11/10/2021
Today
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:HTGM
CIK
1169987
Employees
84
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.59 million
Net Margins
-324.25%
Pretax Margin
-324.05%
Return on Equity
45.52%
Return on Assets
8.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.40
Quick Ratio
1.30

Sales & Book Value

Annual Sales
$6.37 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.44 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,210,000
Free Float
2,156,000
Market Cap
N/A
Optionable
Optionable
Beta
0.99

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:HTGM) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners